Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: Mad2 who wrote (555)	5/8/1999 11:14:00 PM
From: DanZ	Read Replies (2) \| Respond to of 5582

Mad2, <However isn't it true that Gel Tech Industries (now called Biodelivery according to Dan Z) ownes Zicam and Gel Tech LLC is the distribution company?> Biodelivery Technologies does not own Zicam. Prior to signing the operating agreement last week, Biodelivery Technologies and GumTech together owned the intellectual property rights to Zicam. Upon signing of the operating agreement, both companies gave their intellectual property rights to Gel Tech LLC and Gel Tech LLC now owns 100% of the intellectual property rights to Zicam. GumTech owns 60% of Gel Tech LLC and Biodelivery Technologies owns the other 40%. <See new release and copy of ABI listing on Gel Tech Industries.> To the best of my knowledge, Gel Tech Industries and Gel Tech Inc were the same company. Gel Tech Inc filed a corporate name change and is now known as Biodelivery Technologies. They are not doing business as Gel Tech Inc and the ABI listing is outdated. <The whole issue of Gel Tech LLC, Gel Tech Industries and Biodelivery is a bit convoluted and confusing, particularly as it relates to the benifit that will be realized by GUMM shareholders.> GumTech owns 60% of Gel Tech LLC and will receive 60% of the profits from Zicam and any other products that Gel Tech LLC sells. Please review exchange2000.com and let me know what you don't understand. Dan